Latest

psychedelics

This shows the outline of a head with a half moon inside

·April 13, 2021·4 min read

Psychedelic Experience May Not Be Required For Psilocybin’s Antidepressant-Like Benefits

A mouse study refutes the common belief that psilocybin's ability to produce an anti-depressant effect is attributed to the psychedelic experience it creates. Blocking the psychedelic effect did not affect psilocybin's anti-depressant effects.

This shows a blurry outline of a man in blue

Featured Neuroscience Psychology

·April 6, 2021·4 min read

Resurging Psychedelic Therapies for Depression

As interest in using psychedelics to treat a range of mental health disorders grows, researchers consider the impact and therapeutic benefits of using psychedelics to help alleviate symptoms of depression.

Featured Neuroscience Psychology

·March 27, 2021·5 min read

Psychedelic Drugs: How the Brains of Informed Users Are Different

While the effects of hallucinogens to treat mental illnesses are being researched, little is known about the neurobiology of those who dabble in psychedelics for recreational purposes. A new study reports "psychonauts" have distinct behaviors, including taking a scientific approach to documenting their experience with hallucinogens, compared to more recreational users.

This is a spiky psychedelic star which becomes an optical illusion the longer you look at it

Featured Neuroscience Open Neuroscience Articles Psychology

·March 10, 2021·7 min read

Psychedelic Science Holds Promise for Mainstream Medicine

A new study investigates psychedelic medicine on brain activity and the potential for using psychedelics to treat a range of disorders.

This shows a man's fingers holding a tiny blue triangle that looks as though it is made out of felt

Featured Neuroscience Open Neuroscience Articles Psychology

·March 2, 2021·4 min read

Placebo Effect May Explain Reported Benefits of Psychedelic Microdoses

A placebo-controlled study of psychedelics reveals the psychological benefits of microdosing are most likely explained by the placebo effect.

Featured Neuroscience Psychology

·February 21, 2021·4 min read

From Trippy Drugs to Therapeutic Aids – How Psychedelics Got Their Groove Back

From microdosing to improve cognition, to treating a range of mental health disorders, researchers evaluate the rise in the use of psychedelics and their potential as medicines.

Autism Featured Neuroscience Psychology

·January 26, 2021·5 min read

LSD May Offer Viable Treatment for Certain Mental Disorders

LSD increases social behaviors by activating 5-HTPA serotonin receptors and AMPA receptors in the prefrontal cortex, and the mTORC1 protein. Activating all three factors promoted social interactions. The findings suggest supervised LSD microdosing may help alleviate some of the social problems associated with ASD and other mental health disorders that impact social behaviors.

This shows plant leaves and brain scans from the study

Featured Neuroscience Psychology

·January 3, 2021·4 min read

A First Look at How the Psychedelic Salvinorin A Works in the Brain

As with other psychedelics, salvinorin A increased activity across the brain. However, salvinorin A use resulted in more random and disconnected signaling in the default mode network, a brain network associated with relaxing and daydreaming.

Featured Neuroscience Psychology

·December 28, 2020·6 min read

One Psychedelic Experience May Lessen Trauma of Racial Injustice

A single dose of psychedelic treatments can help alleviate symptoms of depression, stress, and trauma in those who have experienced racial injustice.

Featured Neuroscience Psychology

·December 9, 2020·4 min read

New Compound Related to Psychedelic Ibogaine Could Treat Addiction and Depression

Researchers have developed a non-hallucinogenic version of the drug ibogaine which has the potential to treat depression, addiction, anxiety, and a range of other mental health disorders.

Featured Psychology

·November 4, 2020·5 min read

Psychedelic Treatment With Psilocybin Relieves Major Depression

Two doses of psilocybin in combination with therapy rapidly and significantly reduces symptoms in those with major depressive disorder. The effects appear to last for up to four weeks.

Featured Neuroscience Open Neuroscience Articles

·September 17, 2020·6 min read

How Psychedelics Bind to Key Serotonin Receptor

Researchers have uncovered the structure of psychedelic compounds when they actively bind to the 5-HT2A serotonin receptor on the surface of brain cells. The discovery could lead to the exploration of more precise compounds that offer the therapeutic effects of psychedelics for mental health disorders, but without the hallucinations.